The global croscarmellose sodium market is anticipated to surpass a valuation of US$ 900 Mn by the end of 2022, projecting growth at a healthy CAGR of around 5% to 6% during the forecast period 2022-2032. The demand for croscarmellose sodium is estimated to exceed US$ 1,650 Mn by 2032, in comparison to the US$ 850 registered in the year 2021.
| Report Attribute | Details |
|---|---|
| Croscarmellose Sodium Market Registered Base Value (2021) | US$ 850 Million |
| Croscarmellose Sodium Market Expected Value (2022) | US$ 900 Million |
| Croscarmellose Sodium Market Anticipated Value (2032) | US$ 1,650 Million |
| Croscarmellose Sodium Market Projected Growth Rate (2022 to 2032) | 5% to 6% CAGR |
Croscarmellose sodium, also referred to as modified cellulose gum or cross-linked sodium carboxymethyl cellulose, is a white to grayish-white powder with no odor. It is a water-soluble polymer manufactured from wood pulp and cotton linter through various chemical reactions.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The croscarmellose sodium market is largely driven by the swift expansion of the pharmaceutical industry. There has been a rapid surge in the prevalence of various diseases and conditions such as hypertension, cardiovascular disease, cancer, hypercholesterolemia, and others over the last few years, resulting in fueling the demand for pharmaceutical products.
Croscarmellose sodium is gaining huge popularity across the pharmaceutical sector, owing to its advantages such as assistance in fast disintegration & dissolution, enhancing flowability, good mixing properties, and increasing stability of the formulation among others. Attributed to this, it is finding a wide range of applications in the formulation of pharmaceutical products such as therapeutics drugs, capsules, tablets, pellets, and others. Hence, surging demand for pharmaceutical products is projected to bolster the demand for croscarmellose sodium in the global market.
Increasing availability of various others emulsifiers and disintegrants such as crospovidone, sodium starch glycolate, cross-linked alginic acid, and calcium silicate among others are hindering the sales of croscarmellose sodium in the global market.
In addition to this, there are numerous side effects associated with the consumption of croscarmellose sodium such as hepatotoxicity, interstitial nephritis, dyspepsia, fever, pneumonitis, pancreatitis, rashes, pericarditis, and others. Rising awareness regarding these adverse effects is restraining the growth in the market.
Principal Consultant
As per FMI, South Asia is projected to emerge as a highly remunerative market for croscarmellose sodium during the forecast period 2022-2032.
Due to the increasing stressed lifestyle and changing eating habits, the burden of various disorders and health-related diseases such as obesity, diabetes, hypertension, insomnia, and others is rapidly increasing across South Asia, creating strong demand for therapeutics medications.
For instance, according to the International Diabetes Federation, around 74.19 Mn people, or nearly 9.6% of the total population in India were reported to be suffering from diabetes in the year 2021. As croscarmellose sodium plays a vital role in the production of pills, tablets, capsules, and other medications, growing burden of such diseases is anticipated to augment the growth in the South Asia market.
North America is expected to exhibit growth at a rapid CAGR in the global croscarmellose sodium market from 2022 to 2032, states Future Market Insights.
With increasing customer inclination toward packaged food & beverages products, there is a swift rise in demand for ready-to-eat snacks, breakfast cereals, bakery products, dairy products, juices, and others. Hence, key industry players are focusing on launching new products to capitalize on the surging demand.
For instance, in 2021, General Mills, Inc., an American multinational manufacturer of consumer foods, announced its plan of launching a new ready-to-eat cereal lineup including CinnaGraham Toast Crunch, Reese’s Puffs Cluster Crunch, and others. As croscarmellose sodium is used as an emulsifier for the production of aforementioned products, a multiplicity of such new product launches is estimated to favor the growth in the North America market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players in the croscarmellose sodium market are JRS Pharma LP, NB Entrepreneurs, du Pont de Nemours and Company, Maple Biotech Pvt. Ltd., Roquette Frères, Mingtai Chemical Co., Ltd., FMC Corporation, BASF SE, DFE Pharma, Blanver EN, Ashland Inc., Spectrum Chemical Mfg. Corp., and others.
Attributed to the rising adopting capacity expansion, collaboration, mergers & acquisitions strategies, the market for croscarmellose sodium is highly competitive.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5% to 6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Source, Grade, Application, End Use, Region |
| Countries Covered | North America; Latin America; Europe;East Asia; South Asia; Oceania; Middle East and Africa |
| Key Companies Profiled | JRS Pharma LP; NB Entrepreneurs; du Pont de Nemours and Company; Maple Biotech Pvt. Ltd.; Roquette Frères; Mingtai Chemical Co., Ltd.; FMC Corporation; BASF SE; DFE Pharma; Blanver EN; Ashland Inc.; Spectrum Chemical Mfg. Corp.; Others |
| Customization | Available Upon Request |
FMI projects the demand for croscarmellose sodium market to expand at 5% to 6% value CAGR over the forecast period 2022-2032
The croscarmellose sodium market is dominated by South Asia, and this trend is projected to continue for the assessment period.
JRS Pharma LP, NB Entrepreneurs, du Pont de Nemours and Company, Maple Biotech Pvt. Ltd., Roquette Frères, Mingtai Chemical Co., Ltd., FMC Corporation, BASF SE, DFE Pharma, Blanver EN, Ashland Inc., Spectrum Chemical Mfg. Corp., and others are some key croscarmellose sodium manufacturer.
Explore Food and Beverage Insights
View Reports
Croscarmellose Sodium Market
